123 related articles for article (PubMed ID: 3978998)
1. Effect of propranolol on hepatic blood flow in patients with cirrhosis.
Braillon A; Jirón MI; Valla D; Calès P; Lebrec D
Clin Pharmacol Ther; 1985 Apr; 37(4):376-80. PubMed ID: 3978998
[TBL] [Abstract][Full Text] [Related]
2. Beta-blockade with propranolol and hepatic artery blood flow in patients with cirrhosis.
Mastai R; Bosch J; Bruix J; Navasa M; Kravetz D; Rodés J
Hepatology; 1989 Sep; 10(3):269-72. PubMed ID: 2759544
[TBL] [Abstract][Full Text] [Related]
3. Hemodynamic effect of propranolol on portal hypertension in patients with HBsAg-positive cirrhosis.
Kong CW; Lay CS; Tsai YT; Lee SD; Lai KH; Lo KJ; Chiang BN
Dig Dis Sci; 1986 Dec; 31(12):1303-6. PubMed ID: 3803132
[TBL] [Abstract][Full Text] [Related]
4. Effects of somatostatin on hepatic and systemic hemodynamics in patients with cirrhosis of the liver: comparison with vasopressin.
Bosch J; Kravetz D; Rodes J
Gastroenterology; 1981 Mar; 80(3):518-25. PubMed ID: 6108897
[TBL] [Abstract][Full Text] [Related]
5. Propranolol compared with propranolol plus isosorbide-5-mononitrate for portal hypertension in cirrhosis. A randomized controlled study.
García-Pagán JC; Feu F; Bosch J; Rodés J
Ann Intern Med; 1991 May; 114(10):869-73. PubMed ID: 2014947
[TBL] [Abstract][Full Text] [Related]
6. Continuous prazosin administration in cirrhotic patients: effects on portal hemodynamics and on liver and renal function.
Albillos A; Lledó JL; Rossi I; Pérez-Páramo M; Tabuenca MJ; Bañares R; Iborra J; Garrido A; Escartín P; Bosch J
Gastroenterology; 1995 Oct; 109(4):1257-65. PubMed ID: 7557093
[TBL] [Abstract][Full Text] [Related]
7. Effect of propranolol on hepatic blood flow in normal and portal hypertensive rats.
Hillon P; Blanchet L; Lebrec D
Clin Sci (Lond); 1982 Jul; 63(1):29-32. PubMed ID: 7083761
[TBL] [Abstract][Full Text] [Related]
8. Effects of propranolol on renal blood flow and renal function in patients with cirrhosis.
Bataille C; Bercoff E; Pariente EA; Valla D; Lebrec D
Gastroenterology; 1984 Jan; 86(1):129-33. PubMed ID: 6357936
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the short-term effects of mepindolol and propranolol on splanchnic and systemic haemodynamics in patients with cirrhosis.
Braillon A; Calès P; Lebrec D
Int J Clin Pharmacol Res; 1985; 5(4):223-8. PubMed ID: 4055165
[TBL] [Abstract][Full Text] [Related]
10. Discrepancy between wedged hepatic venous pressure and portal venous pressure after acute propranolol administration in patients with alcoholic cirrhosis.
Valla D; Bercoff E; Menu Y; Bataille C; Lebrec D
Gastroenterology; 1984 Jun; 86(6):1400-3. PubMed ID: 6714569
[TBL] [Abstract][Full Text] [Related]
11. Effects of propranolol on hepatic haemodynamics in the cirrhotic and non-cirrhotic rat.
Jenkins SA; Baxter JN; Johnson JN; Devitt P; Shields R
Br J Surg; 1985 May; 72(5):354-8. PubMed ID: 3995241
[TBL] [Abstract][Full Text] [Related]
12. Effects of propranolol on azygos venous blood flow and hepatic and systemic hemodynamics in cirrhosis.
Bosch J; Masti R; Kravetz D; Bruix J; Gaya J; Rigau J; Rodes J
Hepatology; 1984; 4(6):1200-5. PubMed ID: 6500511
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of portal pressure reduction by the association of isosorbide-5-mononitrate to propranolol administration in patients with cirrhosis.
Garcia-Pagán JC; Navasa M; Bosch J; Bru C; Pizcueta P; Rodés J
Hepatology; 1990 Feb; 11(2):230-8. PubMed ID: 2307401
[TBL] [Abstract][Full Text] [Related]
14. The effect of propranolol on portal hypertension in patients with cirrhosis: a hemodynamic study.
Lebrec D; Hillon P; Muńoz C; Goldfarb G; Nouel O; Benhamou JP
Hepatology; 1982; 2(5):523-7. PubMed ID: 6981575
[TBL] [Abstract][Full Text] [Related]
15. Selective and non-selective beta receptor blockade in the reduction of portal pressure in patients with cirrhosis and portal hypertension.
Westaby D; Bihari DJ; Gimson AE; Crossley IR; Williams R
Gut; 1984 Feb; 25(2):121-4. PubMed ID: 6693039
[TBL] [Abstract][Full Text] [Related]
16. Effect on hemodynamics of a liquid meal alone and in combination with propranolol in cirrhosis.
Bendtsen F; Simonsen L; Henriksen JH
Gastroenterology; 1992 Mar; 102(3):1017-23. PubMed ID: 1537493
[TBL] [Abstract][Full Text] [Related]
17. Systemic and hepatic hemodynamics after variceal hemorrhage: effects of propranolol and placebo.
Pomier-Layrargues G; Villeneuve JP; Willems B; Huet PM; Marleau D
Gastroenterology; 1987 Dec; 93(6):1218-24. PubMed ID: 3315825
[TBL] [Abstract][Full Text] [Related]
18. Acute hypotensive effects of oral and intravenous propranolol: early alterations in peripheral resistance.
Fagan TC; Gourley LA; Sawyer PR; Lee JT; Walle T; Gaffney TE
J Clin Hypertens; 1986 Mar; 2(1):21-9. PubMed ID: 3723158
[TBL] [Abstract][Full Text] [Related]
19. [Effects of injectable flunitrazepam on hepatic and cardiac output in man].
Philip F; Pastorino G; Grimaud D; Dolisi C; Maestracci P
Ann Fr Anesth Reanim; 1985; 4(1):14-6. PubMed ID: 3985427
[TBL] [Abstract][Full Text] [Related]
20. Effect of propranolol on hepatic and systemic hemodynamics in dogs with chronic bile duct ligation.
Willems B; Villeneuve JP; Huet PM
Hepatology; 1986; 6(1):92-7. PubMed ID: 3484714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
